Former Chief Operating Officer and Chief Financial Officer · Arcus Biosciences, Inc. (RCUS)

Rekha Hemrajani

FY2019 is the first fiscal year CompBrief holds for Rekha Hemrajani as a named executive officer of Arcus Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,558,524

Salary $233,818Stock awards $0Bonus $200,000

1st of 4 named executive officers at Arcus Biosciences by FY2019 total.

4 named officers on file for Arcus Biosciences, FY2019

Rekha Hemrajani’s pay file — $29

  • 1 fiscal year of pay, line by line
  • RCUS’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arcus Biosciences’s whole pay program stands against its peers

  • Arcus Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RCUS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2020 (DEF 14A).

Free

Get Rekha Hemrajani’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Rekha Hemrajani compensation by year

Arcus Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Arcus Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$233,818
Bonus$200,000
Stock awards$0
Option awards$2,982,440
Non-equity incentive$0
Pension and deferred compensation$0
All other$142,266
Total$3,558,524

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcus Biosciences, Inc. DEF 14A filed April 21, 2020, accession 0001564590-20-017693, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arcus Biosciences, Inc. filed document, accession 0001564590-20-017693. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2020.

Arcus Biosciences’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Rekha Hemrajani · this pageFormer Chief Operating Officer and Chief Financial Officer$3,558,524
William GrossmanFormer Chief Medical Officer$3,400,307
Juan Carlos JaenPresident and Director$2,126,900
Terry RosenChief Executive Officer and Director$1,716,900

The full Arcus Biosciences compensation record

free company brief

This page is one person within Arcus Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Arcus Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcus Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rekha Hemrajani's compensation dossier · One-time report. No refunds.